1. Home
  2. SLRX vs UK Comparison

SLRX vs UK Comparison

Compare SLRX & UK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • UK
  • Stock Information
  • Founded
  • SLRX N/A
  • UK 2015
  • Country
  • SLRX United States
  • UK China
  • Employees
  • SLRX N/A
  • UK N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • UK Business Services
  • Sector
  • SLRX Health Care
  • UK Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • UK Nasdaq
  • Market Cap
  • SLRX 2.1M
  • UK 2.2M
  • IPO Year
  • SLRX N/A
  • UK N/A
  • Fundamental
  • Price
  • SLRX $0.50
  • UK $1.03
  • Analyst Decision
  • SLRX
  • UK
  • Analyst Count
  • SLRX 0
  • UK 0
  • Target Price
  • SLRX N/A
  • UK N/A
  • AVG Volume (30 Days)
  • SLRX 6.2M
  • UK 24.6K
  • Earning Date
  • SLRX 08-19-2025
  • UK 09-26-2025
  • Dividend Yield
  • SLRX N/A
  • UK N/A
  • EPS Growth
  • SLRX N/A
  • UK N/A
  • EPS
  • SLRX N/A
  • UK N/A
  • Revenue
  • SLRX N/A
  • UK $23,924,045.00
  • Revenue This Year
  • SLRX N/A
  • UK N/A
  • Revenue Next Year
  • SLRX N/A
  • UK N/A
  • P/E Ratio
  • SLRX N/A
  • UK N/A
  • Revenue Growth
  • SLRX N/A
  • UK N/A
  • 52 Week Low
  • SLRX $0.45
  • UK $0.98
  • 52 Week High
  • SLRX $7.20
  • UK $1.83
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 37.62
  • UK 46.85
  • Support Level
  • SLRX $0.59
  • UK $0.99
  • Resistance Level
  • SLRX $2.31
  • UK $1.07
  • Average True Range (ATR)
  • SLRX 0.18
  • UK 0.05
  • MACD
  • SLRX -0.02
  • UK -0.00
  • Stochastic Oscillator
  • SLRX 2.27
  • UK 23.81

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

Share on Social Networks: